Delta变异株占优势前后实验室确诊COVID-19住院成人疾病严重程度分析
基于CDC COVID-NET 14州监测数据,比较2021年1-6月(Delta前)与7-8月(Delta期)实验室确诊COVID-19住院成人的重症结局。Delta期18-49岁住院患者比例从24.7%升至35.8%,未接种疫苗者占住院的71.8%,但ICU入住、有创机械通气及院内死亡比例无显著变化。
要点
- Delta期18-49岁住院患者比例显著上升至35.8%。
- Delta期71.8%的COVID-19住院发生在未接种疫苗成人中。
- ICU入住、有创机械通气及院内死亡比例两个时期无显著差异。
核心结论
- Delta变异株占优势期间,住院COVID-19患者中18-49岁成人比例显著增加,但ICU入住、有创机械通气及院内死亡比例较Delta前无显著变化。
- Delta期大多数COVID-19住院发生在未接种疫苗成人中,年轻成人疫苗接种覆盖率较低可能促成住院增加。
研究设计与样本
- 基于CDC COVID-19相关住院监测网络(COVID-NET)的群体监测系统,纳入14个州≥18岁实验室确诊COVID-19住院成人。
- 比较Delta前(2021年1-6月)与Delta期(2021年7-8月)的重症结局趋势,分析对象为完成病历摘录且有出院去向的非妊娠住院患者。
主要发现
- 所有成人COVID-19相关住院率在2021年1-6月下降,7-8月上升。
- 18-49岁住院患者比例从Delta前的24.7%(95%CI=23.2%-26.3%)升至Delta期的35.8%(95%CI=32.1%-39.5%,p<0.01)。
- Delta期71.8%的COVID-19相关住院发生在未接种疫苗成人中。
- Delta期未接种疫苗成人中,18-49岁占住院的43.6%(95%CI=39.1%-48.2%)。
- 非妊娠住院成人的ICU入住、有创机械通气或院内死亡比例在Delta前与Delta期之间无显著变化。
临床怎么用
- 应重视18-49岁成人COVID-19疫苗接种,该年龄组接种率相对较低且Delta期住院比例上升。
- 疫苗接种对所有符合条件成人均关键,包括<50岁人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In mid-June 2021, B.1.671.2 (Delta) became the predominant variant of SARS-CoV-2, the virus that causes COVID-19, circulating in the United States. As of July 2021, the Delta variant was responsible for nearly all new SARS-CoV-2 infections in the United States.* The Delta variant is more transmissible than previously circulating SARS-CoV-2 variants (1); however, whether it causes more severe disease in adults has been uncertain. Data from the CDC COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), a population-based surveillance system for COVID-19-associated hospitalizations, were used to examine trends in severe outcomes in adults aged ≥18 years hospitalized with laboratory-confirmed COVID-19 during periods before (January-June 2021) and during (July-August 2021) Delta variant predominance. COVID-19-associated hospitalization rates among all adults declined during January-June 2021 (pre-Delta period), before increasing during July-August 2021 (Delta period). Among sampled nonpregnant hospitalized COVID-19 patients with completed medical record abstraction and a discharge disposition during the pre-Delta period, the proportion of patients who were admitted to an intensive care unit (ICU), received invasive mechanical ventilation (IMV), or died while hospitalized did not significantly change from the pre-Delta period to the Delta period. The proportion of hospitalized COVID-19 patients who were aged 18-49 years significantly increased, from 24.7% (95% confidence interval [CI] = 23.2%-26.3%) of all hospitalizations in the pre-Delta period, to 35.8% (95% CI = 32.1%-39.5%, p<0.01) during the Delta period. When examined by vaccination status, 71.8% of COVID-19-associated hospitalizations in the Delta period were in unvaccinated adults. Adults aged 18-49 years accounted for 43.6% (95% CI = 39.1%-48.2%) of all hospitalizations among unvaccinated adults during the Delta period. No difference was observed in ICU admission, receipt of IMV, or in-hospital death among nonpregnant hospitalized adults between the pre-Delta and Delta periods. However, the proportion of unvaccinated adults aged 18-49 years hospitalized with COVID-19 has increased as the Delta variant has become more predominant. Lower vaccination coverage in this age group likely contributed to the increase in hospitalized patients during the Delta period. COVID-19 vaccination is critical for all eligible adults, including those aged <50 years who have relatively low vaccination rates compared with older adults.
引用
- Taylor CA, Patel K, Pham H, et al. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34710076. doi:10.15585/mmwr.mm7043e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。